Carl Zeiss Meditec has agreed to collaborate with Oraya Therapeutics and invest in the company’s low-energy radiotherapy treatment for wet age-related macular degeneration, according to a Carl Zeiss Meditec press release.Under the collaboration agreement, Carl Zeiss Meditec will finance the implementation of Oraya’s growth strategy for up to 2 years and receive rights to participate in the company, reaching up to a majority stake after 2 years, the release said.
Face transplantation can dramatically enhance a patient’s quality of life after severe facial trauma, but lack of attention to eyelid function and vision can leave patients with impaired vision, corneal exposure, eyelid retraction that occurs when the …
Orthopedic surgeons are best, and anesthetists worst, at predicting operating theater time, according to orthopedic surgeons from New Zealand. Reuters Health Information
Age at the time of surgery and visual acuity of the treated eye influence stereopsis outcomes in pediatric patients with unilateral cataracts, according to the Infant Aphakia Treatment Study.The randomized clinical trial included 114 patients with unil…
This month, the most-read retina stories on Healio.com included topics that ranged from peer-reviewed journals to the Advanced Retinal Therapy meeting.Here are the top 3 most-read retina stories this month:
Central corneal thickness may be an important mediator regarding the increased risk of glaucoma among black and Hispanic subjects, according to a study.The cross-sectional study consisted of 81,082 subjects older than 40 years who had a central corneal…